High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$53.2M
$53,179,002
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Other
2026-03-11
$65,348x3
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-03-11 | $65,348x3 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2026-03-11
$102,300
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2026-03-11 | $102,300 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Other
2026-02-04
$317,721x3
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-02-04 | $317,721x3 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 SellΔOwn -40.0%
2026-02-04
$580,197x2
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 SellΔOwn -40.0%
|
2026-02-04 | $580,197x2 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2026-01-07
$127,196x6
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2026-01-07 | $127,196x6 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2026-01-07
$220,289
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2026-01-07 | $220,289 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-16 | $7,380,739Whalex10 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $23,278,679MEGAx14 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2025-12-11
$63,598x6
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2025-12-11 | $63,598x6 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-12-11
$107,900
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-12-11 | $107,900 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2025-12-10
$63,598x6
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2025-12-10 | $63,598x6 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-12-10
$105,669
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-12-10 | $105,669 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Sanders Corazon (Corsee) D.
• Director
Equity Compensation
2025-11-26
$417,772x2
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Director
Equity Compensation
|
2025-11-26 | $417,772x2 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Sanders Corazon (Corsee) D.
• Director
Discretionary SellΔOwn -69.4%
2025-11-26
$895,534x2
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Director
Discretionary SellΔOwn -69.4%
|
2025-11-26 | $895,534x2 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Wu Xiaobin
• COO
Discretionary SellΔOwn -79.0%
2025-11-17
$1,518,303Largex3
|
||||||
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary SellΔOwn -79.0%
|
2025-11-17 | $1,518,303Largex3 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Wu Xiaobin
• COO
Discretionary SellΔOwn -70.6%
2025-11-13
$2,286,660Largex2
|
||||||
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary SellΔOwn -70.6%
|
2025-11-13 | $2,286,660Largex2 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Other
2025-11-12
$190,704x3
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-11-12 | $190,704x3 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 SellΔOwn -66.7%
2025-11-12
$347,770x2
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 SellΔOwn -66.7%
|
2025-11-12 | $347,770x2 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary Sell
|
2025-11-12 | $3,560,161Largex8 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Other
2025-10-08
$2,017,363Largex3
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-10-08 | $2,017,363Largex3 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-10-08
$3,739,108Largex4
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-10-08 | $3,739,108Largex4 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -14.6%
|
2025-09-16 | $9,055,694Whalex5 | S | Form 4 |